Calmer Co International Expands Product Range in Coles Supermarkets
CCO (CCO) Share Update July 2024 Monday 29th
Calmer Co International Announces Major Product Range Expansion in Coles Supermarkets
The Calmer Co International Limited (ASX:CCO), a health and wellness company, has announced a significant expansion of its product range in Coles supermarkets across Australia, effective from July 27th.
Instant Summary:
- 40% increase in product listings in Coles supermarkets.
- Instant Kava 150g now available in 632 Coles locations, a 90% increase.
- Taki Mai Kava Shots expanded to 752 locations, a 38% increase.
- Fiji Kava Instant Kava 50g increased to 799 locations.
Expansion Details
The Calmer Co International Limited (ASX:CCO) has announced that Coles Australia will expand the range of the company's products from 1,563 listings to 2,183 listings, marking a 40% increase. This expansion is effective from July 27th and includes several key products.
Instant Kava 150g, the company's most profitable and globally bestselling SKU, will now be available in 632 Coles locations, representing a 90% increase in its range. Taki Mai Kava Shots, which have shown a fast adoption rate, will be available in 752 locations, a 38% increase. Additionally, Fiji Kava Instant Kava 50g, listed in Coles since 2022, will see its range increase to 799 locations.
CEO's Statement
CEO Anthony Noble expressed excitement over the expansion, stating, 'The bottom line is that more products will be stocked by more stores across the Coles national supermarket network. The strong sales growth at Coles demonstrates that kava is now a broader and growing health trend in Australia.'
Noble also highlighted the potential uplift in sales value from the introduction of the 150g SKU into 90% more stores, noting that this product is driving eCommerce growth in both Australia and the USA.
Advertising Campaign
To support the expanded range, the company will run a pilot Out-of-Home advertising campaign focused on Coles supermarkets in New South Wales from late August through September. This campaign aims to increase awareness of the products available in Coles, highlight in-store locations, and promote weekly specials across the range.
Geographical Coverage
The Calmer Co's range of kava products will be sold nationally in Coles, except for the Northern Territory and stores north of Perth in Western Australia and north of Rockhampton in Queensland.
This expansion is likely to have a positive impact on The Calmer Co's stock, as increased product availability in Coles supermarkets could drive higher sales and revenue. The introduction of the company's most profitable product into more stores is particularly promising and may boost investor confidence.
Investor Reaction:
Analysts are likely to react positively to this news, given the significant increase in product listings and the potential for higher sales. However, some may remain cautious until the sales data post-expansion is available.
Conclusion:
Investors should keep an eye on The Calmer Co's performance in the coming months to assess the impact of this expansion on sales and revenue. The company's strategic advertising campaign and increased product availability could lead to substantial growth.